New pain drug could make day surgery safer and faster
NCT ID NCT07409311
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at whether a drug called osellidine can provide good pain relief during hysteroscopic surgery with fewer side effects than traditional opioids. It will involve 310 adults having day surgery. The goal is to see if osellidine leads to fewer breathing problems, less nausea, and quicker recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Osellidine (a painkiller)
- What this could lead to
- If it works, osellidine could offer a safer pain relief option for day surgeries, with fewer side effects and faster recovery.
- What could go wrong
- This is an early feasibility study, not yet recruiting. Results may not apply to all patients, and osellidine's effectiveness compared to standard opioids is still uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GYNECOLOGICAL DAY SURGERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.